Active/Completed Active GrantsCompleted Grants PI Name Sort descending PI Organization Title Grant Number Program Official Fahrmann, Johannes F University Of Tx Md Anderson Can Ctr United States Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer 5U01CA282216-03 Claire Zhu, Ph.D. Farrar, Christian T Massachusetts General Hospital United States Novel metabolomic contrast probes for human lung cancer characterization 4R01CA273010-04 Guillermo Marquez, Ph.D. Feng, Ziding Fred Hutchinson Cancer Center United States Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC) 5U24CA230144-09 Guillermo Marquez, Ph.D. Fiol, Guilherme Del University Of Utah United States GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management 5U24CA274582-03 Christos Patriotis, Ph.D., M.Sc. Forsberg, Flemming Thomas Jefferson University United States Prostate Cancer Diagnosis by Multiparametric Ultrasound 5R01CA252311-05 Frazier, Anne Lindsay Dana-Farber Cancer Inst United States Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors 5UH3CA240688-05 Nicholas Hodges, Ph.D. Fuschiotti, Patrizia University Of Pittsburgh At Pittsburgh United States Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides 5R21CA280445-02 Wendy Wang, Ph.D., M.Sc. Ghobrial, Irene M. Dana-Farber Cancer Inst United States Myeloma multidimensional precancer atlas 4U01CA294507-02 Nicholas Hodges, Ph.D. Ghobrial, Irene M. Dana-Farber Cancer Inst United States Molecular prediction of myeloma in African Americans 5U01CA271492-04 Claire Zhu, Ph.D. Ghosh, Jayashri Temple Univ Of The Commonwealth United States Development of blood-based methylation biomarkers for CRC risk prediction 5R01CA281948-03 Matthew Young, Ph.D. Godwin, Andrew K. University Of Kansas Medical Center United States Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem 5R01CA260132-05 Matthew Young, Ph.D. Goel, Ajay Beckman Research Institute/City Of Hope United States Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer 3U01CA214254-08S2 Matthew Young, Ph.D. Goel, Ajay Beckman Research Institute/City Of Hope United States Exosomal biomarkers for the early detection of hepatocellular carcinoma 5R01CA271443-03 Matthew Young, Ph.D. Goel, Ajay Beckman Research Institute/City Of Hope United States 5mC and 5hmC DNA alterations as sensitive and specific biomarkers for the non-invasive early detection of pancreatic ductal adenocarcinoma 1U01CA296639-01A1 Claire Zhu, Ph.D. Goggins, Michael G. Johns Hopkins University United States Using markers to improve pancreatic cancer screening and surveillance: a multi-center study 5U01CA210170-09 Matthew Young, Ph.D. Pagination « First First page ‹ Previous Previous page … 3 4 5 6 … Next › Next page Last » Last page